Adverse Events, Clinical Considerations and Management Recommendations in Rheumatoid Arthritis Patients Treated with JAK Inhibitors
Exp Rev Clin Immunol 2018 Nov;14(11):945-956. DOI: 10.1080/1744666X.2018.1504678
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Exp Rev Clin Immunol 2018 Nov;14(11):945-956. DOI: 10.1080/1744666X.2018.1504678
Drug Safety 2018 Jul;41(7):645–53
Drug Saf 2018 Apr; 41(4):357–61 DOI: 10.1007/s40264-017-0622-2
Please click the links below to go to the CSF review of each paper.
Nat Rev Drug Discov 2017;16:843–62 DOI: 10.1038/nrd.2017.201
Arthritis Res Ther. 2017 Jul 4;19(1):155. doi: 10.1186/s13075-017-1346-5
Lancet 2017;389:2328–37 DOI 10.1016/S0140-6736(17)31472-1
Arthritis Rheumatol. 2017 Oct;69(10):1949-1959. doi: 10.1002/art.40186
Nature Reviews Rheumatology 2017;13:234–43
Arthritis Rheumatol 2016;68:2867–77